Medicine & Life Sciences
Prostatic Neoplasms
100%
Fluorescence Resonance Energy Transfer
98%
MBD2 protein
90%
Receptor, Fibroblast Growth Factor, Type 2
73%
Cell Line
72%
Cyclin-Dependent Kinase Inhibitor p16
71%
Microfilament Proteins
64%
Organoids
64%
Pharmaceutical Preparations
63%
Esophagogastric Junction
63%
Anthracyclines
55%
Castration
54%
Epigenomics
53%
Internship and Residency
50%
Endometrial Neoplasms
50%
Prostatectomy
50%
Tumor Suppressor Genes
48%
DNA
43%
Mitoxantrone
42%
Neoplasms
41%
Melanoma
40%
Cell Movement
40%
DNA Methylation
32%
Idarubicin
29%
Growth
28%
Clustered Regularly Interspaced Short Palindromic Repeats
28%
Mutation
27%
Methyltransferases
27%
Proteins
26%
MK-1775
22%
Fluorescence Polarization
22%
PHD Zinc Fingers
19%
Ubiquitins
18%
Poisons
18%
Prostate
17%
DNA Demethylation
17%
RNA
17%
Biochemical Phenomena
16%
Growth Inhibitors
16%
Type II DNA Topoisomerase
15%
Decitabine
15%
4,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate)
15%
Protein-Tyrosine Kinases
14%
Demethylation
14%
Preclinical Drug Evaluations
14%
Actin Cytoskeleton
13%
Aurintricarboxylic Acid
13%
Tumor Biomarkers
13%
WEB 2086
13%
Cellular Structures
13%